explore -WSS

explore

author：Wikipedia 2025-10-03 00:38:03 - browse：5

By some measures, private equity investment lagged in 2023, a year marked by growing distress and high-profile downfalls among private equity-backed health care companies.

Even so, three sectors still managed to see strong deal flow and prices: med spa, cardiology, and clinical trial sites, according to a new PitchBook report analyzing private equity investments in health care services in 2023. Each of the three niches continue to generate buzz among investors, even as other areas fizzle.

It’s not that those three industries are perfect fits for private equity, it’s that the more obvious areas like autism therapists and physician practices are struggling with high interest rates and regulatory scrutiny, said Rebecca Springer, PitchBook’s lead health care analyst.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： How the drug

hotspot

explore

WSS

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Flagship Pioneering launches a new biotech in two countries

How the drug

Despite FDA concern, risk that CAR

FDA advisory panel to debate high blood pressure devices

Former Pear Therapeutics executives start new VC firm

explore

explore

explore

Walensky prepares to leave CDC — and Congress — behind

Despite FDA concern, risk that CAR

United colonoscopy coverage change 'may cost lives,' doctors say

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Wildfire smoke exposes gaps in outdoor worker protections

30 years of 'Listening to Prozac'

Walensky prepares to leave CDC — and Congress — behind

Can U.S. cancer drug shortages be fixed?

Medicare details structure of new drug price negotiation program

FDA investigates CAR

knowledge

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Roche's accidental data boosts hopes for anti

Study: Spinal cord stimulation helps patients with paralysis walk again

UnitedHealth’s Optum accused of antitrust violations in California

FDA greenlights medical device to combat bladder issues

Intellia plays down concerns on accidental germline transmission

hotspot

focus

explore

knowledge